Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 26, 2023 - Issue 6
328
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy – a single-center open-label pilot study

, , , , &

References

  • World Health Organization. (2016). Epilepsy fact sheet. Updated February 2016 [Cited 2022 Jan 22]. Available from: http://www.who.int/mediacentre/factsheets/fs999/en/.
  • Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010 Jun;51(6):1069–77. doi:10.1111/j.1528-1167.2009.02397.x. Epub 2009 Nov 3. Erratum in: Epilepsia. 2010 Sep;51(9):1922.
  • Lawn ND, Bamlet WR, Radhakrishnan K, O'Brien PC, So EL. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology. 2004 Nov 9;63(9):1565–70. doi:10.1212/01.wnl.0000142991.14507.b5.
  • Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet. 1999 Mar 13;353(9156):888–93. doi:10.1016/s0140-6736(98)05114-9.
  • Guelpa G, Marie A. La lutte contre l’épilepsie par la désintoxication et par la réduction alimentaire. Revue de Thérapie Médico-Chirurgicale. 1911;78:8–13.
  • Geyelin HR. Fasting as a method for treating epilepsy. Med Rec. 1921;99:1037–1039.
  • Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Charlie foundation; Matthew's friends; practice committee of the child neurology society. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group. Epilepsia Open. 2018 May 21;3(2):175–192. doi:10.1002/epi4.12225.
  • Rahim F, Azizimalamiri R, Sayyah M, Malayeri A. Experimental therapeutic strategies in epilepsies using anti-seizure medications. J Exp Pharmacol. 2021 Mar 11;13:265–290. doi:10.2147/JEP.S267029.
  • Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet–can we be more liberal? Epilepsy Res. 2012 Jul;100(3):278–85. doi:10.1016/j.eplepsyres.2012.06.007. Epub 2012 Jul 6.
  • Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006 Jul;35(1):1–5. doi:10.1016/j.pediatrneurol.2006.01.005.
  • Bergqvist AG. Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res. 2012 Jul;100(3):258–60. doi:10.1016/j.eplepsyres.2011.04.009.
  • Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009 May;50(5):1109–17. doi:10.1111/j.1528-1167.2008.01870.x.
  • Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008 Jun;7(6):500–6. doi:10.1016/S1474-4422(08)70092-9.
  • Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2016 Feb 9;2:CD001903. doi:10.1002/14651858. CD001903.pub3. Update in: Cochrane Database Syst Rev. 2018 Nov 07;11:CD001903.
  • Sinha SR, Kossoff EH. The ketogenic diet. Neurologist. 2005 May;11(3):161–70. doi:10.1097/01.nrl.0000160818.58821.d2.
  • Azzam R, Azar NJ. Marked seizure reduction after MCT supplementation. Case Rep Neurol Med. 2013;2013:809151. doi:10.1155/2013/809151.
  • Wilder RM. The effect of ketonemia on course of epilepsy. The Clinic Bulletin. 1921;2:307.
  • Wheless JW. History of the ketogenic diet. Epilepsia. 2008 Nov;49(Suppl 8):3–5. doi:10.1111/j.1528-1167.2008.01821.x.
  • Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 2018 Jan;17(1):84–93. doi:10.1016/S1474-4422(17)30408-8.
  • Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971 Nov;21(11):1097–103. doi:10.1212/wnl.21.11.1097.
  • Wlaź P, Socała K, Nieoczym D, Łuszczki JJ, Zarnowska I, Zarnowski T, et al. Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology. 2012 Mar;62(4):1882–9. doi:10.1016/j.neuropharm.2011.12.015.
  • Chang P, Augustin K, Boddum K, Williams S, Sun M, Terschak JA, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. 2016 Feb;139(Pt 2):431–43. doi:10.1093/brain/awv325.
  • Verrotti A, Iapadre G, Di Francesco L, Zagaroli L, Farello G. Diet in the treatment of epilepsy: what we know so far. Nutrients. 2020 Aug 30;12(9):2645. doi:10.3390/nu12092645.
  • Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci. 2021 Apr;24(4):307–316. doi:10.1080/1028415X.2019.1627769.
  • Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007 Jan;48(1):43–58. doi:10.1111/j.1528-1167.2007.00915.x.
  • Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009 Mar;59(2):293–315. doi:10.1016/j.brainresrev.2008.09.002.
  • Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The Gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018 Jul 12;174(2):497. doi:10.1016/j.cell.2018.06.051. Erratum for: Cell. 2018 Jun 14;173(7):1728-1741.e13.
  • Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, Wan CM. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017 Dec;13(6):528–536. doi:10.1007/s12519-017-0053-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.